These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1734326)

  • 1. Symptomatic retrochiasmal lesions in multiple sclerosis: clinical features, visual evoked potentials, and magnetic resonance imaging.
    Plant GT; Kermode AG; Turano G; Moseley IF; Miller DH; MacManus DG; Halliday AM; McDonald WI
    Neurology; 1992 Jan; 42(1):68-76. PubMed ID: 1734326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MRI of optic nerve and postchiasmal visual pathways and visual evoked potentials in secondary progressive multiple sclerosis.
    Davies MB; Williams R; Haq N; Pelosi L; Hawkins CP
    Neuroradiology; 1998 Dec; 40(12):765-70. PubMed ID: 9877128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subclinical visual involvement in multiple sclerosis: a study by MRI, VEPs, frequency-doubling perimetry, standard perimetry, and contrast sensitivity.
    Sisto D; Trojano M; Vetrugno M; Trabucco T; Iliceto G; Sborgia C
    Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1264-8. PubMed ID: 15790888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemifield pattern-reversal visual evoked potentials (VEPs) in retrochiasmal lesions with homonymous visual field defect.
    Maccolini E; Andreoli A; Valdé G; Ghini M; Fulco L
    Ital J Neurol Sci; 1986 Aug; 7(4):437-42. PubMed ID: 3759417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bilateral homonymous visual field defects as initial manifestation of multiple sclerosis.
    Sanchez-Dalmau B; Goñi FJ; Guarro M; Roig C; Duch-Bordas F
    Br J Ophthalmol; 1991 Mar; 75(3):185-7. PubMed ID: 2012791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Homonymous visual field defects in patients with multiple sclerosis: results of computerised perimetry and optical coherence tomography.
    Schmutz L; Borruat FX
    Swiss Med Wkly; 2020 Sep; 150():w20319. PubMed ID: 33035355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visual Field Defect Patterns Associated With Lesions of the Retrochiasmal Visual Pathway.
    Cho J; Liao E; Trobe JD
    J Neuroophthalmol; 2022 Sep; 42(3):353-359. PubMed ID: 36166759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value of full-field visual evoked potentials for retrochiasmal lesions.
    Benbadis SR; Lancman ME; Wolgamuth BR; Cheek JC
    J Clin Neurophysiol; 1996 Nov; 13(6):507-10. PubMed ID: 8978622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Congruous quadrantanopia and optic radiation lesion.
    Borruat FX; Siatkowski RM; Schatz NJ; Glaser JS
    Neurology; 1993 Jul; 43(7):1430-2. PubMed ID: 8327151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetic resonance imaging of optic tract involvement in multiple sclerosis.
    Rosenblatt MA; Behrens MM; Zweifach PH; Forman S; Odel JG; Duncan CM; Gross SA
    Am J Ophthalmol; 1987 Jul; 104(1):74-9. PubMed ID: 3605283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are somatosensory evoked potentials of the tibial nerve the most sensitive test in diagnosing multiple sclerosis?
    Djuric S; Djuric V; Zivkovic M; Milosevic V; Jolic M; Stamenovic J; Djordjevic G; Calixto M
    Neurol India; 2010; 58(4):537-41. PubMed ID: 20739788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visual pathway abnormalities were found in most multiple sclerosis patients despite history of previous optic neuritis.
    Castro SM; Damasceno A; Damasceno BP; Vasconcellos JP; Reis F; Iyeyasu JN; Carvalho KM
    Arq Neuropsiquiatr; 2013 Jul; 71(7):437-41. PubMed ID: 23857611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evoked potentials in the evaluation of visual field defects due to chiasmal or retrochiasmal lesions.
    Maitland CG; Aminoff MJ; Kennard C; Hoyt WF
    Neurology; 1982 Sep; 32(9):986-91. PubMed ID: 7202169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations of the optic pathway between unilateral and bilateral optic nerve damage in multiple sclerosis as revealed by the combined use of advanced diffusion kurtosis imaging and visual evoked potentials.
    Takemura MY; Hori M; Yokoyama K; Hamasaki N; Suzuki M; Kamagata K; Kamiya K; Suzuki Y; Kyogoku S; Masutani Y; Hattori N; Aoki S
    Magn Reson Imaging; 2017 Jun; 39():24-30. PubMed ID: 27109488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [VEP in the determination of multiple lesions in the visual system in patients with multiple sclerosis].
    Röder H
    EEG EMG Z Elektroenzephalogr Elektromyogr Verwandte Geb; 1991 Dec; 22(4):234-8. PubMed ID: 1786785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative study of visual evoked potentials and magnetic resonance imaging in multiple sclerosis].
    Miletto G; Merlihot JM; Nezri M; Stanoyevitch JF; Pernet-Rambaud C; Houis B
    J Fr Ophtalmol; 1988; 11(1):67-73. PubMed ID: 3385127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Symptomatic retrochiasmal lesions in multiple sclerosis: clinical features, visual evoked potentials, and magnetic resonance imaging.
    Katz B
    Surv Ophthalmol; 1993; 37(5):387-9. PubMed ID: 8484172
    [No Abstract]   [Full Text] [Related]  

  • 18. Interpretation of visual field defects respecting the vertical meridian and not related to distinct chiasmal or postchiasmal lesions.
    Shikishima K; Kitahara K; Mizobuchi T; Yoshida M
    J Clin Neurosci; 2006 Nov; 13(9):923-8. PubMed ID: 17085298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoimmune optic neuritis in the common marmoset monkey: comparison of visual evoked potentials with MRI and histopathology.
    Diem R; Demmer I; Boretius S; Merkler D; Schmelting B; Williams SK; Sättler MB; Bähr M; Michaelis T; Frahm J; Brück W; Fuchs E
    Invest Ophthalmol Vis Sci; 2008 Aug; 49(8):3707-14. PubMed ID: 18450589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of white matter lesions to gray matter atrophy in multiple sclerosis: evidence from voxel-based analysis of T1 lesions in the visual pathway.
    Sepulcre J; Goñi J; Masdeu JC; Bejarano B; Vélez de Mendizábal N; Toledo JB; Villoslada P
    Arch Neurol; 2009 Feb; 66(2):173-9. PubMed ID: 19204153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.